Under the new organizational structure, Novartis will aim to establish itself as a focused medicines company. The company’s pharmaceuticals and oncology business units will be merged into an Innovative Medicines business with separate US and International commercial organizations. Other divisions such as corporate strategy, R&D portfolio and business development will also be combined to further strengthen the pipeline with high-value medicines. Changes to its Executive Committee have also been announced.

With the new plant, Sumitomo Chemical plans to strengthen its supply of high-quality active pharmaceutical ingredients (APIs) and intermediates in the background of rising demand for small molecule drugs.

Keeping up with complexity — Bioprocesses are complex — thus, frequent measurement and data-driven real time process management are needed to keep complexity in check. The demand for a PAT that guarantees GMP and includes quality by design calls for specialised on-line sensor solutions. And recent technological developments are up to the task ...

Big is beatiful but sometimes small is better. GEA takes its continous granulation and drying concept CosimaGma one step further: with a compact version for lab-scale applications.

Siemens Energy has plans to carry out industrial-scale production of hydrogen electrolyzers in Berlin, Germany in order to boost the concept of green hydrogen. With an investment of more than 30 million dollars, the site is expected to commence production in 2023.

MOL Group has acquired the Hungarian plastic recycling company Remat. With this move, MOL intends to develop customized virgin and recyclate solutions for its customers demanding circular materials.

The need to convey powders is often found in the pharmaceutical industry, especially during production of capsules or tablets, but also in the manufacturing of solubles as these powders are highly complex and delicate and should be handled properly.

Low temperature drying combines seemingly conflicting features such as low temperatures and short drying times while saving energy for the operator.

Lanxess has doubled its membrane capacities for reverse osmosis elements at the plant in Bitterfeld.

Evonik announced that it is investing an amount in the upper double-digit million euro range in the expansion of its fumed silica capacities in Antwerp, Belgium.